Related Experiment Video
Updated: May 26, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Plasma Micro-RNA Signatures of Type 1 Ryanodine Receptor Related Myopathies
Pooja Varma1, Mayra Saintilus2, Morin Nessim2
1Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA.
Researchers identified specific microRNAs (miRNAs) in the plasma of patients with RYR1-related disorders (RYR1-RD). These findings suggest potential new biomarkers for diagnosing this rare neuromuscular condition.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- RYR1 variants cause rare neuromuscular RYR1-related disorders (RYR1-RD) with symptoms like muscle weakness and fatigue.
- Muscle-specific microRNAs (miRNAs) are found in muscle tissue and can be detected in plasma.
- Biomarkers for RYR1-RD are needed for diagnosis and management.
Purpose of the Study:
- To identify and quantify differentially expressed miRNAs in the plasma of adult RYR1-RD patients.
- To explore the potential of these miRNAs as diagnostic biomarkers for RYR1-RD.
Main Methods:
- Plasma samples from six adult RYR1-RD patients (four monoallelic, two biallelic) and controls were analyzed.
- A digital detection system was used to identify and quantify miRNA levels.
- Statistical analysis was performed to identify significant differences in miRNA expression.
Main Results:
- Fifty-one differentially expressed miRNAs were identified between RYR1-RD patients and controls.
- A specific combination, hsa-miR-4454+hsa-miR-7975, was significantly overexpressed (+39-fold, P=0.00285) in patients.
- These findings highlight potential plasma-based indicators for RYR1-RD.
Conclusions:
- Differentially expressed miRNAs in plasma show promise as potential biomarkers for RYR1-RD.
- Further investigation of these miRNAs is warranted for clinical application.
- This study contributes to understanding the molecular pathology of RYR1-RD.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Alterations in Muscle Tone lll
Myasthenia Gravis ll: Pathophysiology
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Cardiomyopathy I: Introduction and Classification
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
